Analysis of Tumor Antigen-Specific Tc1 and Tc2 CD8 Effector Cell Subpopulations as Potential Therapeutics Agents in the Treatment of Progressive Breast

doi 10.21236/ada429842
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Effective Treatment of Established GL261 Murine Gliomas Through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses

PLoS ONE
Multidisciplinary
2015English

Antigen-Specific CD4 Cells Assist CD8 T-Effector Cells in Eliminating Keratinocytes

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2010English

Peptide Vaccine Formulation Controls the Duration of Antigen Presentation and Magnitude of Tumor-Specific CD8+T Cell Response

Journal of Immunology
AllergyImmunology
2018English

Persistent Antigen at Vaccination Sites Induces Tumor-Specific CD8+ T Cell Sequestration, Dysfunction and Deletion

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2013English

MHC-based Detection of Antigen-Specific CD8+ T Cell Responses

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2010English

TIM-3 Engagement Promotes Effector Memory T Cell Differentiation of Human Antigen-Specific CD8 T Cells by Activating mTORC1

Journal of Immunology
AllergyImmunology
2017English

Immunomodulation of Breast Cancer via Tumor Antigen Specific Th1

Cancer Research and Treatment
Cancer ResearchOncology
2009English

Incomplete Differentiation of Antigen-Specific CD8 T Cells in Tumor-Draining Lymph Nodes

Journal of Immunology
AllergyImmunology
2006English

Profound Inhibition of Antigen-Specific T-Cell Effector Functions by Dasatinib

Clinical Cancer Research
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy